COVID-19 associated complications and potential therapeutic targets
JD Monpara, SJ Sodha, PK Gupta - European Journal of Pharmacology, 2020 - Elsevier
The global pandemic COVID-19, caused by novel coronavirus SARS-CoV-2, has emerged
as severe public health issue crippling world health care systems. Substantial knowledge …
as severe public health issue crippling world health care systems. Substantial knowledge …
A comprehensive updated review on SARS‐CoV‐2 and COVID‐19
YR Ren, A Golding, A Sorbello, P Ji… - The Journal of …, 2020 - Wiley Online Library
This literature review aims to provide a comprehensive current summary of the
pathogenesis, clinical features, disease course, host immune responses, and current …
pathogenesis, clinical features, disease course, host immune responses, and current …
Pathophysiology and potential therapeutic candidates for COVID-19: a poorly understood arena
A Samaddar, M Grover, VL Nag - Frontiers in pharmacology, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19), an acute onset pneumonia caused by a novel
Betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged …
Betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged …
COVID-19: A review of the proposed pharmacological treatments
S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
Pharmacological treatments of COVID-19
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …
which was reported for the first time in December 2019, was named by the World Health …
COVID-19 Pandemic: current Challenges and future Perspectives
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lead to the current
pandemic of coronavirus disease 2019 (COVID-19) and more than one hundred million …
pandemic of coronavirus disease 2019 (COVID-19) and more than one hundred million …
Current scenario and future prospect in the management of COVID-19
P Borah, PK Deb, S Deka… - Current Medicinal …, 2021 - ingentaconnect.com
The COVID-19 pandemic continues to wreak havoc worldwide due to the lack of risk
assessment, rapid spreading ability, and propensity to precipitate severe disease in …
assessment, rapid spreading ability, and propensity to precipitate severe disease in …
An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
Clinical characteristics, diagnosis, and therapeutics of covid-19: A review
N Xie, W Zhang, J Chen, F Tian, J Song - Current Medical Science, 2023 - Springer
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that suddenly
emerged at the end of December 2019 and caused coronavirus disease 2019 (COVID-19) …
emerged at the end of December 2019 and caused coronavirus disease 2019 (COVID-19) …
Clinical management of COVID-19: a review of pharmacological treatment options
AM Heustess, MA Allard, DK Thompson, PS Fasinu - Pharmaceuticals, 2021 - mdpi.com
Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …
2020, concerted efforts have been applied by the scientific community to curtail the spread of …